Hong Kong Healthtech Stock News

SEHK:9999
SEHK:9999Entertainment

Is NetEase (SEHK:9999) Pricing Look Attractive After Recent Share Price Pullback

This article examines what the current NetEase share price might be implying about the stock's value, with a particular focus on whether it appears attractively priced or extended. With the stock at HK$183.5 after a 2.5% return over the last week, 3.7% over the last month, a 19.8% decline year to date and a 14.8% return over the past year, many investors are rechecking whether the recent path still lines up with their expectations of risk and reward. Recent coverage around NetEase has...
SEHK:1171
SEHK:1171Oil and Gas

Is Yankuang Energy (SEHK:1171) Quietly Reframing Its Investment Story Through Higher Q1 Profitability?

In April 2026, Yankuang Energy Group Company Limited completed a CNY 2 billion 1.84% fixed-rate medium-term bond due 2029 and reported first-quarter revenue of CNY 34,588.72 million alongside net income of CNY 3,954.97 million, both higher than a year earlier. The earnings release also showed higher basic and diluted earnings per share from continuing operations, highlighting improved profitability alongside the company’s ongoing access to bond markets. We’ll now examine how this improved...
SEHK:1357
SEHK:1357Interactive Media and Services

Why Meitu (SEHK:1357) Is Up 26.2% After AI Agent Upgrade And Record Subscribers

In late April 2026, Meitu unveiled a major upgrade to its imaging AI agent RoboNeo, adding multi-agent “Agent Teams” to automate end-to-end visual content creation across short dramas, social media, and e-commerce, while also reporting record global paying subscribers of 17.90 million as of March 2026 with strong subscription-driven revenue from its photo, video, and design products. This combination of rapid AI product innovation, such as RoboNeo’s Seedance 2.0 video engine and reusable...
SEHK:1211
SEHK:1211Auto

BYD’s Profit And NEV Slump Test Valuation And Growth Expectations

BYD reported significant year on year declines in new energy vehicle production and sales for April 2026. The company also posted a sharp drop in first quarter 2026 net profit and revenue compared with the prior year. These shifts suggest changing demand conditions for electric vehicles that could influence BYD's growth path. For investors watching SEHK:1211, the recent operational and earnings data come against a mixed share price backdrop. BYD trades at around HK$99.75, with the stock...
SEHK:9863
SEHK:9863Auto

Assessing Zhejiang Leapmotor Technology (SEHK:9863) Valuation After Recent Share Price Moves

Why Zhejiang Leapmotor Technology Stock Is Catching Investor Attention Zhejiang Leapmotor Technology (SEHK:9863) has attracted fresh interest after recent trading, with the stock up around 2% on the day and mixed returns over the month and the past 3 months. See our latest analysis for Zhejiang Leapmotor Technology. The recent 2.05% 1 day share price return at HK$47.8 follows a mixed pattern, with a 0.80% 7 day share price return, a 9.81% 30 day share price decline, and an 8.93% 90 day share...
SEHK:386
SEHK:386Oil and Gas

Assessing China Petroleum & Chemical (SEHK:386) Valuation After Recent Share Weakness

Recent share performance and business scale China Petroleum & Chemical (SEHK:386) has drawn attention after a mixed run for the stock, with a slight decline over the past month and a larger negative move over the past 3 months, set against the backdrop of sizeable operations. The company reports annual revenue of CN¥2,754.9b and net income of CN¥36,240m, reflecting a large integrated energy and chemicals business across exploration, refining, marketing, distribution and petrochemicals in...
SEHK:1548
SEHK:1548Life Sciences

A Look At Genscript Biotech (SEHK:1548) Valuation After Recent Share Price Momentum

Why Genscript Biotech Is On Investors’ Radar Genscript Biotech (SEHK:1548) has attracted fresh attention after recent share price moves, with the stock showing positive returns over the past week, month, and past 3 months. This has prompted investors to reassess its fundamentals. See our latest analysis for Genscript Biotech. At the latest share price of HK$15.21, Genscript Biotech has seen momentum build recently, with strong short term share price returns and a 1 year total shareholder...